Boxer Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Boxer Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-400,000	Closed	-$46.1M	–	35
2018 Q1	$46.1M	Buy	+400,000	New	+$42.5M	4.93%	8

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Boxer Capital's LOXO Position: Q2 2018 in Review

Boxer Capital sold out of Loxo Oncology, Inc (LOXO) in Q2 2018, closing a stake of 400,000 shares — an estimated $46.1M sold.

Boxer Capital first reported a position in LOXO in Q1 2018 and held it in 1 quarter. The position peaked at $46.1M in Q1 2018. 213 funds tracked by Wall St. Rank hold LOXO as of Q2 2018.

Boxer Capital reported no remaining Loxo Oncology, Inc position as of Q2 2018 after selling out during the quarter.
Boxer Capital sold 400,000 Loxo Oncology, Inc shares in Q2 2018, an estimated $46.1M.
Boxer Capital first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 1 quarter.
Boxer Capital's Loxo Oncology, Inc position peaked at $46.1M in Q1 2018.
213 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2018.

Based on Boxer Capital's 13F filing for Q2 2018, filed 14 Aug 2018.